PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1401969
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1401969
Hormone Replacement Therapy Market Forecasts to 2030 - Global Analysis By Therapy Type, By Route of Administration, Indication, Distribution Channel and By Geography
According to Stratistics MRC, the Global Hormone Replacement Therapy Market is accounted for $35.8 billion in 2023 and is expected to reach $62.1 billion by 2030 growing at a CAGR of 8.2% during the forecast period. Hormone Replacement Therapy (HRT) involves medical treatments aimed at supplementing or replacing hormones, such as estrogen, progesterone, or testosterone, in individuals experiencing hormonal imbalances due to aging, menopause, or other conditions. HRT can alleviate symptoms like hot flashes, mood swings, and vaginal dryness in women and address hormonal deficiencies in men.
According to World Health Organization (WHO), it is estimated that by 2030, 1 in 6 people will be aged 60 years or more globally and by 2050, the geriatric population is expected to reach 2.1 billion worldwide.
Market Dynamics:
Driver:
Growing prevalence of various hormonal disorders
The increasing prevalence of diverse hormonal disorders serves as a significant driver in the hormone replacement therapy market. Factors such as aging populations, lifestyle changes, and environmental influences contribute to rising incidences of hormonal imbalances, menopause-related symptoms in women and andropause in men. Conditions like hypothyroidism, menopausal symptoms and hormonal deficiencies drive the demand for HRT. This growing patient pool seeking relief from symptoms and complications associated with hormonal disorders fuels the expansion of the hormone replacement therapy market.
Restraint:
High cost of hormone replacement therapy
Expenses for hormone replacement therapy medications, consultations and follow-up visits can be substantial, impacting affordability for many patients. Moreover, insurance coverage and reimbursement limitations often lead to out-of-pocket expenses, limiting accessibility. This financial barrier can deter individuals from seeking or continuing hormone replacement therapy, affecting treatment adherence and overall market growth.
Opportunity:
Rise in drug development with novel delivery systems
Innovative delivery methods, such as transdermal patches, subcutaneous implants and biodegradable microspheres, enhance treatment efficacy, patient compliance and convenience. These advancements offer precise dosing, steady hormone release and reduced side effects compared to traditional oral formulations. They also attract patient interest and expand treatment options, driving market growth by improving therapeutic outcomes and addressing the diverse needs of individuals seeking hormone replacement therapies.
Threat:
Adverse effects of therapies
Hormone therapies, particularly estrogen-based ones, may elevate the risk of blood clots, stroke, breast cancer and cardiovascular complications. These risks vary based on factors like age, dosage, duration of therapy, and individual health history. Concerns about these adverse effects have led to a decline in HRT usage and raised questions about its long-term safety, impacting market growth.
COVID-19 Impact:
The COVID-19 pandemic had varied impacts on the market. Disruptions in healthcare services, including limited access to clinics and reduced elective procedures, affected HRT prescriptions and patient consultations. Heightened health concerns led to delays in seeking hormonal therapies. However, increased awareness of menopausal symptoms and mental health issues during the pandemic might have driven demand for HRT.
The menopause segment is expected to be the largest during the forecast period
During the forecast period, the menopause segment is anticipated to become the largest in the market. As the population ages, the number of women entering menopause increases, leading to a larger demographic seeking therapies to manage menopausal symptoms like hot flashes, night sweats, and mood changes. Additionally, advancements in HRT formulations and delivery methods tailored specifically for menopausal symptoms contribute to the growth of this segment.
The human growth hormone replacement therapy segment is expected to have the highest CAGR during the forecast period
During the forecast period, the human growth hormone (HGH) replacement therapy segment is anticipated to experience robust growth owing to increased awareness of growth hormone deficiencies, coupled with rising instances of hormonal imbalances in adults and children, which is driving demand for HGH therapies. In addition, advancements in biotechnology, leading to the development of innovative HGH formulations and delivery methods, along with expanding applications in addressing various health conditions, are key contributors to the projected substantial growth in this segment.
Region with largest share:
North America is expected to witness the largest market share, due to the advanced healthcare infrastructure, high healthcare expenditure, and a significant emphasis on research and development. Moreover, the prevalence of hormonal imbalances, coupled with an aging population seeking hormone therapies, contributes to substantial market growth. Favorable reimbursement policies and the presence of key market players further reinforce North America's dominance in the market.
Region with highest CAGR:
Asia Pacific is poised for robust growth in the market due to the region's expanding aging population, coupled with increasing awareness of menopausal symptoms and hormonal disorders. Additionally, rapid urbanization, lifestyle changes, and a growing focus on healthcare have heightened the prevalence of hormonal imbalances, propelling market growth. Moreover, improving healthcare infrastructure, rising disposable incomes and evolving regulatory frameworks are facilitating greater accessibility to fostering substantial growth in the Asia Pacific region.
Key players in the market:
Some of the key players in Hormone Replacement Therapy Market include AbbVie Inc., Acerus Pharmaceuticals, Amgen, Bausch Health Companies, Bayer AG, Eli Lilly and Company, Merck & Co., Mithra Pharmaceuticals SA, Mylan NV, Novartis AG, Novo Nordisk, Pfizer Inc., QuatRx Pharmaceuticals, Radius Health, Sanofi, Serum Institute of India, Teva Pharmaceutical Industries, TherapeuticsMD and Veru Inc.
Key Developments:
In August 2022, Akorn announced that it had successfully received FDA approval for launching its Generic-Cetrorelix Acetate in the form of Injection (0.25 mg quantity). Cetrorelix is one of the most effective chemicals used in hormone replacement therapy as it totally blocks the adverse impacts of a natural hormone, known as GnRH or gonadotropin-releasing hormone.
In February 2022, MHLW of Japan approved NGENLA of Pfizer, Inc. and OPKO which is a long-lasting treatment for pediatric growth hormone deficiency. This strategic initiative helps the companies to expand their customer base in different geography and boost their revenue.
Therapy Types Covered:
- Estrogen Hormone Replacement Therapy
- Human Growth Hormone Replacement Therapy
- Oestrogen Hormone Replacement Therapy
- Parathyroid Hormone Replacement Therapy
- Progestogen Hormone Replacement Therapy
- Testosterone Hormone Replacement Therapy
- Thyroid Hormone Replacement Therapy
- Other Therapy Types
Route of Administrations Covered:
- Oral
- Parenteral
- Transdermal
- Other Route of Administrations
Indications Covered:
- Menopause
- Growth Hormone Deficiency
- Hypothyroidism
- Male Hypogonadism
- Other Indications
Distribution Channels Covered:
- Retail Pharmacies and Drugstores
- Online Pharmacies
- Other Distribution Channels
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 Emerging Markets
- 3.7 Impact of Covid-19
4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
5 Global Hormone Replacement Therapy Market, By Therapy Type
- 5.1 Introduction
- 5.2 Estrogen Hormone Replacement Therapy
- 5.3 Human Growth Hormone Replacement Therapy
- 5.4 Oestrogen Hormone Replacement Therapy
- 5.5 Parathyroid Hormone Replacement Therapy
- 5.6 Progestogen Hormone Replacement Therapy
- 5.7 Testosterone Hormone Replacement Therapy
- 5.8 Thyroid Hormone Replacement Therapy
- 5.9 Other Therapy Types
6 Global Hormone Replacement Therapy Market, By Route of Administration
- 6.1 Introduction
- 6.2 Oral
- 6.3 Parenteral
- 6.4 Transdermal
- 6.5 Other Route of Administrations
7 Global Hormone Replacement Therapy Market, By Indication
- 7.1 Introduction
- 7.2 Menopause
- 7.3 Growth Hormone Deficiency
- 7.4 Hypothyroidism
- 7.5 Male Hypogonadism
- 7.6 Other Indications
8 Global Hormone Replacement Therapy Market, By Distribution Channel
- 8.1 Introduction
- 8.2 Retail Pharmacies and Drugstores
- 8.3 Online Pharmacies
- 8.4 Other Distribution Channels
9 Global Hormone Replacement Therapy Market, By Geography
- 9.1 Introduction
- 9.2 North America
- 9.2.1 US
- 9.2.2 Canada
- 9.2.3 Mexico
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 Italy
- 9.3.4 France
- 9.3.5 Spain
- 9.3.6 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 New Zealand
- 9.4.6 South Korea
- 9.4.7 Rest of Asia Pacific
- 9.5 South America
- 9.5.1 Argentina
- 9.5.2 Brazil
- 9.5.3 Chile
- 9.5.4 Rest of South America
- 9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 UAE
- 9.6.3 Qatar
- 9.6.4 South Africa
- 9.6.5 Rest of Middle East & Africa
10 Key Developments
- 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 10.2 Acquisitions & Mergers
- 10.3 New Product Launch
- 10.4 Expansions
- 10.5 Other Key Strategies
11 Company Profiling
- 11.1 AbbVie Inc.
- 11.2 Acerus Pharmaceuticals
- 11.3 Amgen
- 11.4 Bausch Health Companies
- 11.5 Bayer AG
- 11.6 Eli Lilly and Company
- 11.7 Merck & Co.
- 11.8 Mithra Pharmaceuticals SA
- 11.9 Mylan NV
- 11.10 Novartis AG
- 11.11 Novo Nordisk
- 11.12 Pfizer Inc.
- 11.13 QuatRx Pharmaceuticals
- 11.14 Radius Health
- 11.15 Sanofi
- 11.16 Serum Institute of India
- 11.17 Teva Pharmaceutical Industries
- 11.18 TherapeuticsMD
- 11.19 Veru Inc.
List of Tables
- Table 1 Global Hormone Replacement Therapy Market Outlook, By Region (2021-2030) ($MN)
- Table 2 Global Hormone Replacement Therapy Market Outlook, By Therapy Type (2021-2030) ($MN)
- Table 3 Global Hormone Replacement Therapy Market Outlook, By Estrogen Hormone Replacement Therapy (2021-2030) ($MN)
- Table 4 Global Hormone Replacement Therapy Market Outlook, By Human Growth Hormone Replacement Therapy (2021-2030) ($MN)
- Table 5 Global Hormone Replacement Therapy Market Outlook, By Oestrogen Hormone Replacement Therapy (2021-2030) ($MN)
- Table 6 Global Hormone Replacement Therapy Market Outlook, By Parathyroid Hormone Replacement Therapy (2021-2030) ($MN)
- Table 7 Global Hormone Replacement Therapy Market Outlook, By Progestogen Hormone Replacement Therapy (2021-2030) ($MN)
- Table 8 Global Hormone Replacement Therapy Market Outlook, By Testosterone Hormone Replacement Therapy (2021-2030) ($MN)
- Table 9 Global Hormone Replacement Therapy Market Outlook, By Thyroid Hormone Replacement Therapy (2021-2030) ($MN)
- Table 10 Global Hormone Replacement Therapy Market Outlook, By Other Therapy Types (2021-2030) ($MN)
- Table 11 Global Hormone Replacement Therapy Market Outlook, By Route of Administration (2021-2030) ($MN)
- Table 12 Global Hormone Replacement Therapy Market Outlook, By Oral (2021-2030) ($MN)
- Table 13 Global Hormone Replacement Therapy Market Outlook, By Parenteral (2021-2030) ($MN)
- Table 14 Global Hormone Replacement Therapy Market Outlook, By Transdermal (2021-2030) ($MN)
- Table 15 Global Hormone Replacement Therapy Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
- Table 16 Global Hormone Replacement Therapy Market Outlook, By Indication (2021-2030) ($MN)
- Table 17 Global Hormone Replacement Therapy Market Outlook, By Menopause (2021-2030) ($MN)
- Table 18 Global Hormone Replacement Therapy Market Outlook, By Growth Hormone Deficiency (2021-2030) ($MN)
- Table 19 Global Hormone Replacement Therapy Market Outlook, By Hypothyroidism (2021-2030) ($MN)
- Table 20 Global Hormone Replacement Therapy Market Outlook, By Male Hypogonadism (2021-2030) ($MN)
- Table 21 Global Hormone Replacement Therapy Market Outlook, By Other Indications (2021-2030) ($MN)
- Table 22 Global Hormone Replacement Therapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 23 Global Hormone Replacement Therapy Market Outlook, By Retail Pharmacies and Drugstores (2021-2030) ($MN)
- Table 24 Global Hormone Replacement Therapy Market Outlook, By Online Pharmacies (2021-2030) ($MN)
- Table 25 Global Hormone Replacement Therapy Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
- Table 26 North America Hormone Replacement Therapy Market Outlook, By Country (2021-2030) ($MN)
- Table 27 North America Hormone Replacement Therapy Market Outlook, By Product (2021-2030) ($MN)
- Table 28 North America Hormone Replacement Therapy Market Outlook, By Therapy Type (2021-2030) ($MN)
- Table 29 North America Hormone Replacement Therapy Market Outlook, By Estrogen Hormone Replacement Therapy (2021-2030) ($MN)
- Table 30 North America Hormone Replacement Therapy Market Outlook, By Human Growth Hormone Replacement Therapy (2021-2030) ($MN)
- Table 31 North America Hormone Replacement Therapy Market Outlook, By Oestrogen Hormone Replacement Therapy (2021-2030) ($MN)
- Table 32 North America Hormone Replacement Therapy Market Outlook, By Parathyroid Hormone Replacement Therapy (2021-2030) ($MN)
- Table 33 North America Hormone Replacement Therapy Market Outlook, By Progestogen Hormone Replacement Therapy (2021-2030) ($MN)
- Table 34 North America Hormone Replacement Therapy Market Outlook, By Testosterone Hormone Replacement Therapy (2021-2030) ($MN)
- Table 35 North America Hormone Replacement Therapy Market Outlook, By Thyroid Hormone Replacement Therapy (2021-2030) ($MN)
- Table 36 North America Hormone Replacement Therapy Market Outlook, By Other Therapy Types (2021-2030) ($MN)
- Table 37 North America Hormone Replacement Therapy Market Outlook, By Route of Administration (2021-2030) ($MN)
- Table 38 North America Hormone Replacement Therapy Market Outlook, By Oral (2021-2030) ($MN)
- Table 39 North America Hormone Replacement Therapy Market Outlook, By Parenteral (2021-2030) ($MN)
- Table 40 North America Hormone Replacement Therapy Market Outlook, By Transdermal (2021-2030) ($MN)
- Table 41 North America Hormone Replacement Therapy Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
- Table 42 North America Hormone Replacement Therapy Market Outlook, By Indication (2021-2030) ($MN)
- Table 43 North America Hormone Replacement Therapy Market Outlook, By Menopause (2021-2030) ($MN)
- Table 44 North America Hormone Replacement Therapy Market Outlook, By Growth Hormone Deficiency (2021-2030) ($MN)
- Table 45 North America Hormone Replacement Therapy Market Outlook, By Hypothyroidism (2021-2030) ($MN)
- Table 46 North America Hormone Replacement Therapy Market Outlook, By Male Hypogonadism (2021-2030) ($MN)
- Table 47 North America Hormone Replacement Therapy Market Outlook, By Other Indications (2021-2030) ($MN)
- Table 48 North America Hormone Replacement Therapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 49 North America Hormone Replacement Therapy Market Outlook, By Retail Pharmacies and Drugstores (2021-2030) ($MN)
- Table 50 North America Hormone Replacement Therapy Market Outlook, By Online Pharmacies (2021-2030) ($MN)
- Table 51 North America Hormone Replacement Therapy Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
- Table 52 Europe Hormone Replacement Therapy Market Outlook, By Country (2021-2030) ($MN)
- Table 53 Europe Hormone Replacement Therapy Market Outlook, By Product (2021-2030) ($MN)
- Table 54 Europe Hormone Replacement Therapy Market Outlook, By Therapy Type (2021-2030) ($MN)
- Table 55 Europe Hormone Replacement Therapy Market Outlook, By Estrogen Hormone Replacement Therapy (2021-2030) ($MN)
- Table 56 Europe Hormone Replacement Therapy Market Outlook, By Human Growth Hormone Replacement Therapy (2021-2030) ($MN)
- Table 57 Europe Hormone Replacement Therapy Market Outlook, By Oestrogen Hormone Replacement Therapy (2021-2030) ($MN)
- Table 58 Europe Hormone Replacement Therapy Market Outlook, By Parathyroid Hormone Replacement Therapy (2021-2030) ($MN)
- Table 59 Europe Hormone Replacement Therapy Market Outlook, By Progestogen Hormone Replacement Therapy (2021-2030) ($MN)
- Table 60 Europe Hormone Replacement Therapy Market Outlook, By Testosterone Hormone Replacement Therapy (2021-2030) ($MN)
- Table 61 Europe Hormone Replacement Therapy Market Outlook, By Thyroid Hormone Replacement Therapy (2021-2030) ($MN)
- Table 62 Europe Hormone Replacement Therapy Market Outlook, By Other Therapy Types (2021-2030) ($MN)
- Table 63 Europe Hormone Replacement Therapy Market Outlook, By Route of Administration (2021-2030) ($MN)
- Table 64 Europe Hormone Replacement Therapy Market Outlook, By Oral (2021-2030) ($MN)
- Table 65 Europe Hormone Replacement Therapy Market Outlook, By Parenteral (2021-2030) ($MN)
- Table 66 Europe Hormone Replacement Therapy Market Outlook, By Transdermal (2021-2030) ($MN)
- Table 67 Europe Hormone Replacement Therapy Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
- Table 68 Europe Hormone Replacement Therapy Market Outlook, By Indication (2021-2030) ($MN)
- Table 69 Europe Hormone Replacement Therapy Market Outlook, By Menopause (2021-2030) ($MN)
- Table 70 Europe Hormone Replacement Therapy Market Outlook, By Growth Hormone Deficiency (2021-2030) ($MN)
- Table 71 Europe Hormone Replacement Therapy Market Outlook, By Hypothyroidism (2021-2030) ($MN)
- Table 72 Europe Hormone Replacement Therapy Market Outlook, By Male Hypogonadism (2021-2030) ($MN)
- Table 73 Europe Hormone Replacement Therapy Market Outlook, By Other Indications (2021-2030) ($MN)
- Table 74 Europe Hormone Replacement Therapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 75 Europe Hormone Replacement Therapy Market Outlook, By Retail Pharmacies and Drugstores (2021-2030) ($MN)
- Table 76 Europe Hormone Replacement Therapy Market Outlook, By Online Pharmacies (2021-2030) ($MN)
- Table 77 Europe Hormone Replacement Therapy Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
- Table 78 Asia Pacific Hormone Replacement Therapy Market Outlook, By Country (2021-2030) ($MN)
- Table 79 Asia Pacific Hormone Replacement Therapy Market Outlook, By Product (2021-2030) ($MN)
- Table 80 Asia Pacific Hormone Replacement Therapy Market Outlook, By Therapy Type (2021-2030) ($MN)
- Table 81 Asia Pacific Hormone Replacement Therapy Market Outlook, By Estrogen Hormone Replacement Therapy (2021-2030) ($MN)
- Table 82 Asia Pacific Hormone Replacement Therapy Market Outlook, By Human Growth Hormone Replacement Therapy (2021-2030) ($MN)
- Table 83 Asia Pacific Hormone Replacement Therapy Market Outlook, By Oestrogen Hormone Replacement Therapy (2021-2030) ($MN)
- Table 84 Asia Pacific Hormone Replacement Therapy Market Outlook, By Parathyroid Hormone Replacement Therapy (2021-2030) ($MN)
- Table 85 Asia Pacific Hormone Replacement Therapy Market Outlook, By Progestogen Hormone Replacement Therapy (2021-2030) ($MN)
- Table 86 Asia Pacific Hormone Replacement Therapy Market Outlook, By Testosterone Hormone Replacement Therapy (2021-2030) ($MN)
- Table 87 Asia Pacific Hormone Replacement Therapy Market Outlook, By Thyroid Hormone Replacement Therapy (2021-2030) ($MN)
- Table 88 Asia Pacific Hormone Replacement Therapy Market Outlook, By Other Therapy Types (2021-2030) ($MN)
- Table 89 Asia Pacific Hormone Replacement Therapy Market Outlook, By Route of Administration (2021-2030) ($MN)
- Table 90 Asia Pacific Hormone Replacement Therapy Market Outlook, By Oral (2021-2030) ($MN)
- Table 91 Asia Pacific Hormone Replacement Therapy Market Outlook, By Parenteral (2021-2030) ($MN)
- Table 92 Asia Pacific Hormone Replacement Therapy Market Outlook, By Transdermal (2021-2030) ($MN)
- Table 93 Asia Pacific Hormone Replacement Therapy Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
- Table 94 Asia Pacific Hormone Replacement Therapy Market Outlook, By Indication (2021-2030) ($MN)
- Table 95 Asia Pacific Hormone Replacement Therapy Market Outlook, By Menopause (2021-2030) ($MN)
- Table 96 Asia Pacific Hormone Replacement Therapy Market Outlook, By Growth Hormone Deficiency (2021-2030) ($MN)
- Table 97 Asia Pacific Hormone Replacement Therapy Market Outlook, By Hypothyroidism (2021-2030) ($MN)
- Table 98 Asia Pacific Hormone Replacement Therapy Market Outlook, By Male Hypogonadism (2021-2030) ($MN)
- Table 99 Asia Pacific Hormone Replacement Therapy Market Outlook, By Other Indications (2021-2030) ($MN)
- Table 100 Asia Pacific Hormone Replacement Therapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 101 Asia Pacific Hormone Replacement Therapy Market Outlook, By Retail Pharmacies and Drugstores (2021-2030) ($MN)
- Table 102 Asia Pacific Hormone Replacement Therapy Market Outlook, By Online Pharmacies (2021-2030) ($MN)
- Table 103 Asia Pacific Hormone Replacement Therapy Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
- Table 104 South America Hormone Replacement Therapy Market Outlook, By Country (2021-2030) ($MN)
- Table 105 South America Hormone Replacement Therapy Market Outlook, By Product (2021-2030) ($MN)
- Table 106 South America Hormone Replacement Therapy Market Outlook, By Therapy Type (2021-2030) ($MN)
- Table 107 South America Hormone Replacement Therapy Market Outlook, By Estrogen Hormone Replacement Therapy (2021-2030) ($MN)
- Table 108 South America Hormone Replacement Therapy Market Outlook, By Human Growth Hormone Replacement Therapy (2021-2030) ($MN)
- Table 109 South America Hormone Replacement Therapy Market Outlook, By Oestrogen Hormone Replacement Therapy (2021-2030) ($MN)
- Table 110 South America Hormone Replacement Therapy Market Outlook, By Parathyroid Hormone Replacement Therapy (2021-2030) ($MN)
- Table 111 South America Hormone Replacement Therapy Market Outlook, By Progestogen Hormone Replacement Therapy (2021-2030) ($MN)
- Table 112 South America Hormone Replacement Therapy Market Outlook, By Testosterone Hormone Replacement Therapy (2021-2030) ($MN)
- Table 113 South America Hormone Replacement Therapy Market Outlook, By Thyroid Hormone Replacement Therapy (2021-2030) ($MN)
- Table 114 South America Hormone Replacement Therapy Market Outlook, By Other Therapy Types (2021-2030) ($MN)
- Table 115 South America Hormone Replacement Therapy Market Outlook, By Route of Administration (2021-2030) ($MN)
- Table 116 South America Hormone Replacement Therapy Market Outlook, By Oral (2021-2030) ($MN)
- Table 117 South America Hormone Replacement Therapy Market Outlook, By Parenteral (2021-2030) ($MN)
- Table 118 South America Hormone Replacement Therapy Market Outlook, By Transdermal (2021-2030) ($MN)
- Table 119 South America Hormone Replacement Therapy Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
- Table 120 South America Hormone Replacement Therapy Market Outlook, By Indication (2021-2030) ($MN)
- Table 121 South America Hormone Replacement Therapy Market Outlook, By Menopause (2021-2030) ($MN)
- Table 122 South America Hormone Replacement Therapy Market Outlook, By Growth Hormone Deficiency (2021-2030) ($MN)
- Table 123 South America Hormone Replacement Therapy Market Outlook, By Hypothyroidism (2021-2030) ($MN)
- Table 124 South America Hormone Replacement Therapy Market Outlook, By Male Hypogonadism (2021-2030) ($MN)
- Table 125 South America Hormone Replacement Therapy Market Outlook, By Other Indications (2021-2030) ($MN)
- Table 126 South America Hormone Replacement Therapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 127 South America Hormone Replacement Therapy Market Outlook, By Retail Pharmacies and Drugstores (2021-2030) ($MN)
- Table 128 South America Hormone Replacement Therapy Market Outlook, By Online Pharmacies (2021-2030) ($MN)
- Table 129 South America Hormone Replacement Therapy Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
- Table 130 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Country (2021-2030) ($MN)
- Table 131 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Product (2021-2030) ($MN)
- Table 132 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Therapy Type (2021-2030) ($MN)
- Table 133 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Estrogen Hormone Replacement Therapy (2021-2030) ($MN)
- Table 134 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Human Growth Hormone Replacement Therapy (2021-2030) ($MN)
- Table 135 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Oestrogen Hormone Replacement Therapy (2021-2030) ($MN)
- Table 136 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Parathyroid Hormone Replacement Therapy (2021-2030) ($MN)
- Table 137 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Progestogen Hormone Replacement Therapy (2021-2030) ($MN)
- Table 138 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Testosterone Hormone Replacement Therapy (2021-2030) ($MN)
- Table 139 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Thyroid Hormone Replacement Therapy (2021-2030) ($MN)
- Table 140 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Other Therapy Types (2021-2030) ($MN)
- Table 141 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Route of Administration (2021-2030) ($MN)
- Table 142 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Oral (2021-2030) ($MN)
- Table 143 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Parenteral (2021-2030) ($MN)
- Table 144 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Transdermal (2021-2030) ($MN)
- Table 145 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
- Table 146 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Indication (2021-2030) ($MN)
- Table 147 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Menopause (2021-2030) ($MN)
- Table 148 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Growth Hormone Deficiency (2021-2030) ($MN)
- Table 149 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Hypothyroidism (2021-2030) ($MN)
- Table 150 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Male Hypogonadism (2021-2030) ($MN)
- Table 151 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Other Indications (2021-2030) ($MN)
- Table 152 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 153 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Retail Pharmacies and Drugstores (2021-2030) ($MN)
- Table 154 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Online Pharmacies (2021-2030) ($MN)
- Table 155 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
